Allworth Financial’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
Other funds holding NVCR
Allworth Financial's NVCR Position: Q2 2026 in Review
Allworth Financial increased its NovoCure (NVCR) stake by 182% in Q2 2026, buying an estimated $26.6K and bringing the position to 2,721 shares worth $41.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2655.
Allworth Financial first reported a position in NVCR in Q3 2021 and has held it in 19 quarters since. 218 funds tracked by Wall St. Rank hold NVCR as of Q2 2026.
- Allworth Financial held 2,721 shares of NovoCure worth $41.2K as of Q2 2026.
- Allworth Financial bought 1,756 NovoCure shares in Q2 2026, an estimated $26.6K.
- NovoCure made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #2655 holding.
- Allworth Financial first reported a position in NovoCure in Q3 2021 and has held it in 19 quarters since.
- 218 funds tracked by Wall St. Rank held NovoCure as of Q2 2026.
Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.